Skip to main content

Table 2 Results of pulmonary function tests and symptom scores recorded at baseline (visit 1) and after 2 days (visit 2) and 7 days (visit 3) of treatment with deflazacort or prednisolone in pediatric patients with moderate asthma exacerbation. Reproduced with permission from [11]

From: Deflazacort: therapeutic index, relative potency and equivalent doses versus other corticosteroids

  Visit 1 Visit 2 Visit 3
  Deflazacort Prednisolone Deflazacort Prednisolone Deflazacort Prednisolone
FEV1 (%) 53 (13.3) 51 (14.9) 75* (15.8) 78* (20.3) 86*,** (14.3) 84* (18.6)
PEFR (l/min) 169.3 (65.3) 165.4 (79.3) 233* (84.7) 214 (75.5) 285* (113.4) 253* (114.8)
Symptom scores 6.1 (1.4) 6.5 (1.4) 1.7* (1.2) 2.7* (1.2) 0.7*,** (0.8) 0.6*,** (0.8)
  1. *Significantly different (p < 0.05) versus visit 1; **Significantly different (p < 0.05) versus visit 2; FEV1: Forced Expiratory Volume in one second; PEFR: Peak Expiratory Flow Rate